Global Prostate Cancer Devices Market Growth (Status and Outlook) 2023-2029

Global Prostate Cancer Devices Market Growth (Status and Outlook) 2023-2029

Prostate cancer is cancer that starts in the prostate gland, a walnut sized gland at the base of the bladder in men. The treatment options for men with prostate cancer might include: surgery, brachytherapy, radiotherapy, hormonotherapy, chemotherapy, high intensity focused ultrasound (HIFU) and cryotherapy. In this report, the research team studied the robotic surgery, high intensity focused ultrasound (HIFU), cryotherapy, brachytherapy, and external beam radiation.

LPI (LP Information)' newest research report, the “Prostate Cancer Devices Industry Forecast” looks at past sales and reviews total world Prostate Cancer Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Prostate Cancer Devices sales for 2023 through 2029. With Prostate Cancer Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Prostate Cancer Devices industry.

This Insight Report provides a comprehensive analysis of the global Prostate Cancer Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Prostate Cancer Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Prostate Cancer Devices market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Prostate Cancer Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Prostate Cancer Devices.

The global Prostate Cancer Devices market size is projected to grow from US$ 2911.6 million in 2022 to US$ 6576.5 million in 2029; it is expected to grow at a CAGR of 12.3% from 2023 to 2029.

North America is the largest Prostate Cancer Devices market with about 49% market share. Europe is follower, accounting for about 27% market share.

The key players are Intuitive Surgical, Varian Medical Systems, Elekta, Accuray, Bard Medical (BD), Eckert & Ziegler, Healthtronics, EDAP TMS, SonaCare Medical, Galil Medical (BTG) etc. Top 5 companies occupied about 91% market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Prostate Cancer Devices market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

Robotic Surgery Devices

EBRT Devices

Brachytherapy

HIFU Devices

Cryotherapy Devices

Segmentation by application

Hospitals

Ambulatory Surgical Centers

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Intuitive Surgical

Varian Medical Systems

Elekta

Accuray

Bard Medical (BD)

Eckert & Ziegler

Healthtronics

EDAP TMS

SonaCare Medical

Galil Medical (BTG)

Please note: The report will take approximately 2 business days to prepare and deliver.